Business expansion
Slovenija; Osrednjeslovenska;
Location of affected unit(s)
Mengeš, Zagorje ob Savi
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.10 - Manufacture of basic pharmaceutical products

100 jobs
Number of planned job creations
Job creation
Announcement Date
13 October 2022
Employment effect (start)
1 November 2022
Foreseen end date
31 December 2023


The pharmaceutical company Lek, located in Ljubljana and part of the Swiss-based Sandoz group (Novartis), has announced a plan for creating 100 new jobs at its Biopharmaceutics unit in Mengeš, which currently has 300 employees. The unit has been awarded ‘Factory of the Year 2022’ for most successful implementation of the Industry 4.0 concept among Slovenian companies, by standing out with its technological advances in production, employee care, concern for sustainable development and business. The announcement for the recruitment of 100 new employees was made by the production unit director, Polonca Kovač, during her award acceptance speech. Kovač also announced that the factory- a producer of active ingredients for biologics and biosimilars- plans to quadruple the production capacity of one of its subunits in Zagorje ob Savi within the next two years (2023 and 2024).

Currently the company employs 4797 people in Slovenia.

Previous business restructurings were recorded in the ERM database in 2020, with 140 jobs created (Lek-2020-SI), in 2019, with 320 jobs cut (Lek-2019-SI) and in 2016, with 100 jobs created (Lek-2016-SI).



Eurofound (2022), Lek, Business expansion in Slovenia, factsheet number 107618, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/107618.